Granisetron FDA Link Generic

A serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic for cancer chemotherapy patients.

Also Known As:

Kytril; BRL-43694; BRL-43694A; Granisetron Hydrochloride; Granisetron Monohydrochloride; BRL 43694; BRL 43694A; BRL43694; BRL43694A; Hydrochloride, Granisetron; Monohydrochloride, Granisetron; 1- methyl- N- (endo- 9- methyl- 9- azabicyclo(3.3.1)non- 3- yl)- 1H- indazole- 3- carboxamide; 1H-Indazole-3-carboxamide, 1- methyl- N- (9- methyl- 9- azabicyclo(3.3.1)non- 3- yl; 1H-Indazole-3-carboxamide, 1- methyl- N- (9- methyl- 9- azabicyclo(3.3.1)non- 3- yl)- , endo-

Pharmalogical Action Categories:

Antiemetics

Organic Chemicals: 140
- Aza Compounds: 3
  - Azabicyclo Compounds
    - Granisetron: 901
Heterocyclic Compounds: 207
- 1-Ring Heterocyclic Compounds
  - Azoles: 2199
    - Pyrazoles: 61
      - Indazoles: 183
        Granisetron: 901
- Bridged-Ring Heterocyclic Compounds
  - Heterocyclic Bridged Bicyclo Compounds: 1
    - Azabicyclo Compounds
      - Granisetron: 901
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indazoles: 183
      - Granisetron: 901

J Hanousek Selected Research

J Hanousek Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure